|
|
||||||||
a Cardiothoracic Intensive Care Unit, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina
b Department of Cardiology, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina
c Department of Hematology, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina
d Department of Cardiothoracic Surgery, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina
Accepted for publication February 6, 2009.
* Address correspondence to Dr Benzadón, Instituto Cardiovascular de Buenos Aires, Blanco Encalada 1543, Buenos Aires, C1428DCO, Argentina (Email: marianobenzadon{at}yahoo.com.ar).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The patient was a 52-year-old man who had been diagnosed with O-R-W disease 20 years earlier and presented with gastrointestinal, nasal, and bronchi telangiectasias, and hepatic arteriovenous malformations (AVMs). He was being treated with a daily dose of danazol (200 mg), vitamin C (50 mg), and flavonoids (450 mg) to prevent bleeding, and ferrous sulfate (40 mg) for anemia. He had been hospitalized 80 times in the last 2 years because of severe bleeding from the respiratory and gastrointestinal tract.
The patient was sent to our institution after sustaining an acute myocardial infarction with shock, secondary to anemia due to a massive epistaxis that required multiple transfusions, mechanical ventilation, and support with inotropic drugs. A transthoracic echocardiogram showed a severe aortic valve stenosis, with a peak pressure gradient of 92 mm Hg, a velocity of 4.8 m/s, an area of 0.7 cm2, and an ejection fraction of 0.51. No lesions were found on coronary angiography.
After the patient was stabilized, an urgent aortic valve replacement was performed. To avoid anticoagulation, a St Jude No. 23 (St. Jude Medical, St. Paul, MN) bioprosthesis was implanted within a total operation time of 250 minutes and a cardiopulmonary bypass time of 75 minutes. The patient recovered satisfactorily, without bleeding in the early postoperative period, and was discharged on day 5. He was not treated with aspirin because of his high hemorrhagic risk. After a 1-year follow-up, the patient did not experience any new bleeding complications.
| Comment |
|---|
|
|
|---|
Cardiopulmonary bypass causes several changes in hemostasis that increase the risk of hemorrhage in the early postoperative period. These alterations tend to be worse with longer cardiopulmonary bypass time [4]. It is possible that the short cardiopulmonary bypass exposure in our patient might have helped to reduce the early postoperative blood loss. In addition with this patient, we carefully focused on keeping the activated clotting time at more than 400 seconds, a measure that seems to prevent bleeding due to lower coagulation system activation [5].
The lack of severe hemorrhagic complications observed in the ambulatory follow-up of our patient may have been related to aortic valve replacement. Aortic stenosis tends to increase venous pressure, which could enhance the risk of telangiectasias and AVM bleeding, similar to what happens in patients with Heyde syndrome (aortic valve stenosis and colonic vascular ectasias) [6]. As expected in our patient, left ventricle filling pressures were significantly reduced as estimated by conventional and tissue Doppler studies after the operation.
Aortic stenosis may also be associated with the von Willebrand acquired syndrome, which tends to resolve when the aortic stenosis is surgically corrected [7]. The disappearance of these mechanisms after the operation may explain the abrupt cessation of hemorrhages observed in our patient in the late follow-up. However, we cannot confirm this hypothesis because we did not test our patient for von Willebrand disease.
Our results are similar to those previously reported by Seike and colleagues [1], according to which a 75-year-old woman with aortic stenosis was operated on and recovered without any early bleeding complications. In contrast with our patient, Seike and colleagues did not report the late postoperative course.
The postoperative course of our patient was uneventful and there was no untoward bleeding. It appears that the surgical correction of aortic valve stenosis in patients with O-R-W disease can reduce episodes of hemorrhage in the late follow-up. This hypothesis calls for further evaluation.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
F. Shikata, M. Nagashima, K. Kawachi, Y. Seike, S. Takano, and T. Hori Open Heart Surgery for Hereditary Hemorrhagic Telangiectasia Ann. Thorac. Surg., June 1, 2010; 89(6): 2074 - 2075. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |